Norflex

Muscle Pain, Bursitis, Pain + 17 more

Treatment

7 FDA approvals

20 Active Studies for Norflex

What is Norflex

Orphenadrine

The Generic name of this drug

Treatment Summary

A muscarinic antagonist is a type of medication used to reduce the symptoms of drug-induced parkinsonism and to relieve pain from muscle spasms.

Norflex

is the brand name

image of different drug pills on a surface

Norflex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Norflex

Orphenadrine

1959

68

Approved as Treatment by the FDA

Orphenadrine, otherwise called Norflex, is approved by the FDA for 7 uses which include Muscle Spasms and Musculoskeletal Diseases .

Muscle Spasms

Musculoskeletal Diseases

Used to treat mild Musculoskeletal Disorder in combination with Acetylsalicylic acid

other pain relief measures

Used to treat other pain relief measures in combination with Acetylsalicylic acid

Physical Therapy

Used to treat Physical Therapy in combination with Acetylsalicylic acid

Rest

Used to treat Rest in combination with Acetylsalicylic acid

Spasm

Musculoskeletal Diseases

Used to treat moderate Musculoskeletal Disorder in combination with Acetylsalicylic acid

Effectiveness

How Norflex Affects Patients

Orphenadrine is a medication prescribed to help reduce muscle discomfort related to a variety of musculoskeletal conditions. It works by blocking certain nerve signals in the brain, and has a mild effect in reducing histamines and providing local anesthesia. Orphenadrine is also used to treat Parkinson's Disease and similar conditions. It helps restore the balance between chemicals that control movement in the brain, which can help reduce stiffness and shaking associated with Parkinson's. It is not as effective in treating slowed movement associated with the condition.

How Norflex works in the body

Orphenadrine works by blocking two types of receptors in the body. The first is the histamine H1 receptor, which helps regulate movement. The second is the NMDA receptor, which helps control mood. By blocking these receptors, orphenadrine can reduce muscle spasms and have a calming effect. It can also help improve mood.

When to interrupt dosage

The measure of Norflex is contingent upon the diagnosed affliction, including Musculoskeletal Diseases, Mild pain and Musculoskeletal Diseases. The quantity of dosage also differs, in accordance with the mode of delivery (e.g. Liquid or Liquid - Intramuscular; Intravenous) specified in the table beneath.

Condition

Dosage

Administration

Muscle Pain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Fever

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Sprains and Strains

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Musculoskeletal Diseases

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Wounds and Injuries

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Muscle Strain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Mild pain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Pain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Inflammation

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Musculoskeletal Diseases

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Musculoskeletal Diseases

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

other pain relief measures

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Bursitis

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Pain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Physical Therapy

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Rheumatism

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Rest

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Dysmenorrhea

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Spasm

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Low Back Pain

30.0 mg/mL, , 100.0 mg, 50.0 mg, 25.0 mg, 60.0 mg/mL

Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, , Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Tablet, Tablet - Oral, Liquid, Liquid - Intramuscular; Intravenous

Warnings

Norflex has eight contraindications and should not be utilized in the presence of any of the conditions indicated in the table below.

Norflex Contraindications

Condition

Risk Level

Notes

Prostatic Hyperplasia

Do Not Combine

Peptic Ulcer

Do Not Combine

Duodenal Obstruction

Do Not Combine

Esophageal Achalasia

Do Not Combine

Pyloric Stenosis

Do Not Combine

Open-angle glaucoma

Do Not Combine

Urinary Bladder Neck Obstruction

Do Not Combine

Myasthenia Gravis

Do Not Combine

There are 20 known major drug interactions with Norflex.

Common Norflex Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Orphenadrine.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Orphenadrine.

Acebutolol

Major

The metabolism of Acebutolol can be decreased when combined with Orphenadrine.

Aclidinium

Major

The risk or severity of adverse effects can be increased when Orphenadrine is combined with Aclidinium.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Orphenadrine.

Norflex Toxicity & Overdose Risk

The toxic dose of the drug in mice has been found to be 100 mg/kg and in rats it is 255 mg/kg when taken orally.

image of a doctor in a lab doing drug, clinical research

Norflex Novel Uses: Which Conditions Have a Clinical Trial Featuring Norflex?

220 active studies are being conducted to investigate the potential of Norflex in mitigating Osteoarthritis, Dysmenorrhea and Musculoskeletal Ailments.

Condition

Clinical Trials

Trial Phases

Musculoskeletal Diseases

2 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Dysmenorrhea

1 Actively Recruiting

Not Applicable

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Mild pain

0 Actively Recruiting

Rest

0 Actively Recruiting

Wounds and Injuries

7 Actively Recruiting

Not Applicable, Phase 3

Rheumatism

0 Actively Recruiting

other pain relief measures

0 Actively Recruiting

Spasm

0 Actively Recruiting

Sprains and Strains

0 Actively Recruiting

Pain

0 Actively Recruiting

Pain

0 Actively Recruiting

Muscle Pain

3 Actively Recruiting

Phase 4, Not Applicable, Phase 2

Inflammation

0 Actively Recruiting

Bursitis

0 Actively Recruiting

Musculoskeletal Diseases

0 Actively Recruiting

Low Back Pain

8 Actively Recruiting

Not Applicable, Phase 4, Phase 1

Muscle Strain

0 Actively Recruiting

Physical Therapy

6 Actively Recruiting

Not Applicable

Musculoskeletal Diseases

0 Actively Recruiting

Norflex Reviews: What are patients saying about Norflex?

5

Patient Review

3/17/2011

Norflex for Muscle Spasm

I unfortunately did not experience any relief from this medication, even though I have a pulled muscle in my chest wall.

4.7

Patient Review

4/16/2011

Norflex for Muscle Spasm

This medication is really helpful for me because I have a genetic disorder in my lower back. It often causes pain there and in my left leg and ankle when I over exert myself, but this allows me to sleep restfully and wake up without any stiffness.

4.3

Patient Review

7/30/2012

Norflex for Muscle Spasm

Norflex has been a godsend for me, allowing me to avoid surgery for my chronic neck and back pain.

3.7

Patient Review

1/9/2012

Norflex for Muscle Spasm

I've been using Norflex for over a year now, and just recently started having blurred vision about three months ago. It's gotten to the point where it was difficult to pass my state license exam, even with glasses. I contacted my pharmacist who said to reach out to my doctor. My doctor wants me to stop taking the medication and see if that helps; so, I'm going to give it at least two months.

3.3

Patient Review

4/18/2012

Norflex for Muscle Spasm

I took this for some really bad back spasms. It let me get on with my life while I was taking it, but I started getting muscle twitches all over my body that I never had before. After a week or so of taking the medicine, I stopped and hope the twitching goes away soon.

3

Patient Review

5/10/2017

Norflex for Muscle Spasm

I was prescribed disipal/norflex for the burning sensation I experience in my legs when inactive. After taking it for five days, I saw some improvement but then the symptoms would come back a few hours later. I also experienced some of the listed side effects, so I'm hesitant to increase the dose as directed.

2.7

Patient Review

10/24/2013

Norflex for Muscle Spasm

I had to stop taking this after only two doses because I developed an allergic reaction. It was just some mild itchiness and a rash, but it was enough that I didn't want to risk continuing. While I was taking it, I didn't really notice much of a difference in my muscle spasms.

2.7

Patient Review

4/25/2013

Norflex for Muscle Spasm

I've been struggling with chronic pain for a while now, and I haven't found anything that really helps. Trigger point injections and epidurals provide some relief, but it never lasts very long.

2.7

Patient Review

5/19/2010

Norflex for Muscle Spasm

It's alright, I guess.

2.7

Patient Review

6/15/2011

Norflex for Muscle Spasm

I have neuropathy and this is the best muscle relaxer I've ever taken. I'm glad I tried something new.

2.3

Patient Review

11/8/2016

Norflex for Muscle Spasm

My daughter received a shot in her hip for muscle pain and strain. However, I was never informed that this could potentially harm my baby if I were to breastfeed while she had the medication in her system.

2.3

Patient Review

1/2/2011

Norflex for Muscle Spasm

This treatment helps with the muscles in my back and legs.

2

Patient Review

9/8/2009

Norflex for Muscle Spasm

1.3

Patient Review

2/12/2011

Norflex for Muscle Spasm

Unfortunately, this medicine did not work for me. I was in pain a mere hour after taking it, and it's incredibly overpriced.

Patient Q&A Section about norflex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Will Norflex make you sleepy?

"If you experience any of the following symptoms while taking NORFLEX, do not operate machinery or drive: blurred vision, drowsiness, dizziness, lightheadedness, or fainting. NORFLEX may also cause muscle weakness."

Answered by AI

Is Norflex a painkiller?

"- Norflex is a muscle relaxant. It is usually used together with rest and physical therapy to treat conditions that cause pain or injury in the skeletal muscles. Norflex may also be used for other purposes that are not listed in this medication guide."

Answered by AI

Is Norflex a good muscle relaxer?

"Studies have shown that drugs that relax the muscles, like Norflex, are effective, have tolerable side effects, and can help treat painful conditions that come with muscle spasms."

Answered by AI

Is Norflex used for anxiety?

"Norflex (orphenadrine) alleviates stress. Valium (diazepam) is ideal for infrequent or ephemeral usage for nuisances and muscle spasm. Valium (diazepam) works rapidly, but can have reactions with other drugs, in comparison to similar drugs."

Answered by AI

Clinical Trials for Norflex

Image of St. John's Rehab at Sunnybrook in Toronto, Canada.

Peer Support Program for Traumatic Injury

18+
All Sexes
Toronto, Canada

Traumatic injuries from events like car crashes, falls, or fires are a leading cause of disability. Survivors often face not only physical challenges but also long-lasting pain, mental health challenges and difficulty returning to work and family life. Although medical care focuses on physical recovery, survivors frequently report that their emotional and social needs are overlooked and unmet. Peer support-guidance from people who have lived through similar injuries-can reduce distress and improve coping. However, no programs in Canada currently provide peer support to trauma survivors across their recovery journey, from hospital to rehabilitation to community living. The investigators worked with trauma survivors, caregivers, and healthcare providers to co-design a Peer Support Program (PSP) that offers support throughout these stages. This pilot study will test whether the program is feasible and acceptable, and explore its early impact on recovery. Results will guide a future larger trial to expand peer support in trauma care.

Waitlist Available
Has No Placebo

St. John's Rehab at Sunnybrook (+1 Sites)

Marina Wasilewski, PhD

Image of Medical University of South Carolina in Charleston, United States.

SPRINT PNS System for Lower Back Pain

18+
All Sexes
Charleston, SC

Chronic lower back pain is a significant cause of disability, affecting 21-68% of people 60 years of age and older (source). Of these cases, 15-30% are attributed to posterior sacroiliac joint complex (PSIJC) pain (source), making it a target for treatment. Peripheral Nerve Stimulation (PNS) is a procedure that involves the placement of a lead under the skin with local anesthetic and electrically stimulating designated spinal nerves that deliver pain signals to the brain. It has emerged as a promising alternative to drug, injection, and radioablative therapies. Its use has been supported by previous studies of subjects who received permanent neurostimulation and experienced benefits such as decreased sensation of pain and perceived level of disability. SPRINT is a minimally invasive PNS system of interest due to its ability to provide long-term pain relief after temporary administration of PNS. The aim of this study is to understand whether the FDA-cleared SPRINT PNS system is safe and effective for the treatment of chronic PSIJC pain. This prospective clinical study will assess 10 subjects that meet the inclusion and exclusion criteria across 5 separate time points- 1.) Screening; 2.) Procedure within 3 months of screening; 3.) 12-day post-procedure follow-up; 4.) 3-month post-procedure follow-up; 5.) 3-Month post lead removal follow-up. The subjects will be required to complete physical examinations, and VAS and ODI questionnaires at timepoints 3, 4, and 5.

Recruiting
Has No Placebo

Medical University of South Carolina

Ameet Nagpal

SPR Therapeutics, Inc.

Image of Walter Reed National Military Medical Center in Bethesda, United States.

Corticosteroid Injections for Osteoarthritis

18+
All Sexes
Bethesda, MD

The goal of this clinical trial is to find out which type of steroid medicine, when added to a standard pain-control injection during total knee replacement surgery, works best at reducing pain, limiting opioid use, and improving recovery in adults undergoing surgery for severe knee arthritis or injury. The main questions it aims to answer are: Does adding a steroid to the injection improve pain control and reduce opioid use after surgery? Is the newer extended-release steroid (Zilretta) more effective and safer-especially for patients with diabetes-than the traditional steroid (methylprednisolone)? Researchers will compare: Standard pain-control injection alone Standard injection plus methylprednisolone Standard injection plus Zilretta to see which option provides better pain relief, less opioid use, and improved knee function. (Patients with diabetes or prediabetes will only be in the standard injection or Zilretta groups so researchers can study whether Zilretta is safer for blood sugar control.) Participants will: Be randomly assigned to one of the study groups during their total knee replacement surgery Receive the assigned pain-control injection around the knee joint Be followed after surgery to measure: Pain levels Opioid pain medication use Knee movement (range of motion) Whether another procedure (such as manipulation under anesthesia) is needed if the knee becomes too stiff Patient-reported outcome surveys about pain and function

Phase 2 & 3
Waitlist Available

Walter Reed National Military Medical Center

John P Cody, MD

Have you considered Norflex clinical trials?

We made a collection of clinical trials featuring Norflex, we think they might fit your search criteria.
Go to Trials
Image of Rutgers School of Dental Medicine in Newark, United States.

Temporo-masseteric Nerve Block for Postoperative Pain

18+
All Sexes
Newark, NJ

The proposed design is a triple-blind, placebo-controlled randomized prospective phase II trial to assess the feasibility of employing the Temporo-masseteric Nerve Block (TMNB) injection to decrease jaw muscle pain, overall pain, improve mouth opening and minimize pain medication consumption. 80 participants undergoing lower third molar removal under sedation will be enrolled. Those who develop significant jaw muscle pain on the following day will be randomized to receive either the TMNB injection or a placebo. Daily ecological momentary assessments (EMAs) will be collected reflecting elements of patient experience for all participants. On Day 8, participants return for an end-of-study evaluation and return their unused pain medications. Up to 40 participants who are randomized to receive TMNB/placebo will be recruited to participate in a qualitative interview regarding their experience.

Phase 2
Waitlist Available

Rutgers School of Dental Medicine

Image of School of Allied Health Professions in Loma Linda, United States.

Seed Cycling for Menstrual Disorder

18 - 45
Female
Loma Linda, CA

The purpose of this research is to investigate the impact of seed cycling on menstrual regularity, cramps, and pre-menstrual symptoms in women with an irregular menstrual cycle and/or dysmenorrhea. The research seeks to provide evidence-based insights into the potential benefits of seed cycling as a holistic approach to women's reproductive health. It is expected that your participation will last 3 months. Procedures and Activities. You will be provided with and asked to consume specific seeds daily. The seeds are to be consumed as follows: follicular phase (the period from the first day of menstruation (day 1) to ovulation (day 14) in a typical 28-day cycle): 1 tablespoon flax seeds and 1 tablespoon pumpkin seeds, and luteal phase (the period between ovulation and the start of the next period; typically days 15-28): 1 tablespoon sunflower seeds and 1 tablespoon sesame seeds. Before the intervention and once monthly for a total of 3 cycles, you will be asked to complete an online menstrual health symptom questionnaire (MHSQ) and keep track of your menstrual cycle days on the built-in health tracking app on your electronic device. Risks. Some of the foreseeable risks or discomforts of your participation include the potential for mild gastrointestinal side effects, the potential for allergic reactions, and the possibility of no significant benefit. Benefits. Possible benefits include the potential for improved menstrual cycle regularity, the potential for a reduction in premenstrual syndrome (PMS) symptoms, and the potential for nutritional benefits. Societal benefits include additional knowledge on seed cycling to help manage menstrual regularity and PMS symptoms.

Waitlist Available
Has No Placebo

School of Allied Health Professions

Have you considered Norflex clinical trials?

We made a collection of clinical trials featuring Norflex, we think they might fit your search criteria.
Go to Trials
Image of University of Alberta in Edmonton, Canada.

Dry Needling for Physical Therapy

18+
All Sexes
Edmonton, Canada

The goal of this clinical trial is to learn if the addition of cadaver review improves: * the accuracy of physiotherapists who practice dry needling. * the perceived safety of dry needling by physiotherapists. Researchers will compare the effects of an anatomy review using cadaver material to that of an educational intervention not related to anatomy to see if the anatomy review improves the needling accuracy and safety of physiotherapist who practice dry needling as compared to the control intervention of education not related to anatomy. Participants will: * Needle three muscles related to safety and/or accuracy using ultrasound imaging to gather accuracy and safety measurements. * Take an initial knowledge exam capturing their knowledge on needling safety. * Be randomized into a control group or intervention group. * The control group will receive an online educational session not related to anatomy. * The intervention group will receive a cadaver anatomy review class focused on high-risk area. * Re-take a knowledge exam after their course (either cadaver lab or on-line education) to capture any change. * Needle the same three muscles again using ultrasound to capture accuracy and safety measurements. If reviewing anatomy using cadaver materials improve physiotherapists needling accuracy and safety, then this educational intervention could be recommended to be added to dry needling course instruction.

Recruiting
Paid Trial

University of Alberta

Eric Parent, PhD

Have you considered Norflex clinical trials?

We made a collection of clinical trials featuring Norflex, we think they might fit your search criteria.
Go to Trials